News
Vertex shares fell in after-hours trading, as investors considered a stock trading near its all-time high with a longer wait ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
VANCOUVER, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc ... 19827430.0 for its lead chronic kidney disease (CKD) program drug NP-251 (Repirinast).
Get his next trade alert for free, right here. Vertex Pharmaceuticals Inc VRTX is entering earnings week with some serious anticipation — and a bit of heartburn. The stock had a solid run in ...
announced today that it has filed a patent infringement lawsuit in the United Kingdom against Vertex Pharmaceuticals and its commercial manufacturing partners, Lonza and RoslinCT, regarding Vertex ...
$1,600,000 of VERTEX PHARMACEUTICALS INCORPORATED lobbying ... General education about kidney disease, including APOL-1; Cystic Fibrosis; Sickle cell disease; Innovations in Type 1 diabetes ...
Oral infections are more likely to occur in people with chronic kidney disease and are more likely to become a significant problem. Proper dental care also benefits people on dialysis or those ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The list, however, does include Indian-origin Reshma Kewalramani, the US-based CEO of Vertex Pharmaceuticals ... therapy that treats sickle cell disease, a landmark in genomic medicine.
A lower apixaban dose is indicated in patients with an eGFR less than 30 mL/min/1.73 m2, regardless of dialysis status. Impaired kidney function is the principal predictor of hemorrhage in ...
Kidney disease is a severe condition in which your kidneys slowly start to fail. This leads to a build-up of harmful elements in your blood that would otherwise be filtered out through your kidneys.
April 15 (UPI) --A patient with end-stage kidney disease successfully received a genetically engineered porcine kidney and was released from the hospital in February, according to biotech firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results